Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Gain Therapeutics Presents Positive Phase 1b Open-Label Extension Data For Rexaceract Demonstrating Further Evidence of Disease-Modifying Activity Through 12 Months Administration

Gain Therapeutics presented positive 12-month open-label extension data from its Phase 1b study of rexaceract in Parkinson's disease patients. The data showed stabilization of motor scores (MDS-UPDRS Parts II and III) with no significant disease progression or safety concerns, supporting the drug’s disease-modifying potential. The company plans to …

Quantum X Labs Files for U.S. Patent to LayerQake, a Quantum Cybersecurity Technology Designed to Detect Rare and Anomalous Events

Quantum X Labs Files for U.S. Patent to LayerQake, a Quantum Cybersecurity Technology Designed to Detect Rare and Anomalous Events

Quantum X Labs Inc. announced that its subsidiary has filed a U.S. patent application for LayerQake, a quantum cybersecurity technology designed to detect and localize rare anomalous activities using advanced quantum stratified inference and Bayesian analysis. The technology targets high-dimensional data environments and has applications in defense…

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Ernexa Therapeutics CEO Corner Highlights Appointment of Dr. Robert J. Spiegel as Company Sharpens Oncology Focus and Advances ERNA-101 Toward the Clinic

Ernexa Therapeutics announced the appointment of Dr. Robert J. Spiegel to its Board of Directors, bringing significant oncology and clinical development expertise as the company focuses on advancing its lead cell therapy candidate ERNA-101 toward clinical trials. Encouraging preclinical data showed complete tumor clearance and 100% survival in ovar…

Giftify’s CardCash Deploys AI-Powered Customer Service Tools to Cut Response Times by More Than 90%

Giftify’s CardCash Deploys AI-Powered Customer Service Tools to Cut Response Times by More Than 90%

Giftify, Inc., operator of CardCash.com and Restaurant.com, has deployed an AI-powered customer service system that has reduced average response times by more than 90% without increasing staffing costs. This innovation helps gather necessary information before inquiries reach human agents, improving efficiency. Operational changes, including better…

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

European Medicines Agency Validates PolyPid’s Marketing Authorization Application for D-PLEX₁₀₀

PolyPid Ltd. announced that the European Medicines Agency (EMA) has validated its Marketing Authorization Application (MAA) for D-PLEX100, its lead product candidate for preventing post-abdominal surgical site infections. This validation confirms a complete application and initiates formal EMA review. Concurrently, the FDA has accepted D-PLEX100's …

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Definitive Healthcare Joins the Network Advertising Initiative to Strengthen Data Privacy Compliance in Healthcare Marketing

Definitive Healthcare, a US-based healthcare data and analytics provider, announced its membership in the Network Advertising Initiative (NAI) to reinforce its commitment to responsible data stewardship and strict privacy standards. This move enhances confidence among its healthcare advertising customers by ensuring compliance with complex federal …

FingerMotion and BlueFlare Sign Binding Agreement to Acquire 20-Acre Site in Hanna, Alberta, Establishing Hanna Campus #1 for AI Inference Compute

FingerMotion and BlueFlare Sign Binding Agreement to Acquire 20-Acre Site in Hanna, Alberta, Establishing Hanna Campus #1 for AI Inference Compute

FingerMotion, Inc. (Nasdaq: FNGR) has entered into a binding agreement with BlueFlare Group Holdings Inc. to acquire a 20.2-acre site in Hanna, Alberta. The site, named Hanna Campus #1, will be developed into an AI inference compute campus powered by a combination of local grid electricity and behind-the-meter natural gas generation with a total ca…

Access Is Becoming Manufacturing’s Competitive Advantage, According to Xometry's 2027 U.S. Manufacturing Outlook

Access Is Becoming Manufacturing’s Competitive Advantage, According to Xometry's 2027 U.S. Manufacturing Outlook

Xometry released its 2027 U.S. Manufacturing Outlook report, emphasizing a shift in manufacturing competitive advantage from owning assets to having access to capacity, qualified suppliers, and AI-driven intelligence. Key trends include AI's upstream impact on manufacturability and costing, underutilized capacity in smaller manufacturers, the growi…

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

AIM ImmunoTech Spotlights Growing Attention Around Ampligen® Pancreatic Cancer Strategy as DURIPANC Advances Toward Topline Data

AIM ImmunoTech Inc. highlights growing media attention and clinical progress in its development of Ampligen® (rintatolimod) for metastatic pancreatic cancer. The Phase 2 DURIPANC trial combining Ampligen with AstraZeneca's Imfinzi is advancing, with final Ampligen dosing completed and topline results anticipated in early 2027. Prior Named Patient P…

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

Outlook Therapeutics has submitted an application to the Centers for Medicare & Medicaid Services (CMS) requesting a permanent, product-specific HCPCS Level II J-code for its FDA-approved ophthalmic drug LYTENAVA, used in treating wet age-related macular degeneration (wet AMD). The move aims to facilitate reimbursement, streamline billing, and enha…

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Lexeo Therapeutics Announces Oral Presentation of LX2006 at the International Congress of Parkinson’s Disease and Movement Disorders 2026 (MDS)

Lexeo Therapeutics announced that its gene therapy candidate LX2006 will be orally presented at the International Congress of Parkinson's Disease and Movement Disorders 2026. The presentation will highlight early positive neurologic outcomes from Phase 1 and 2 studies indicating stabilization or improvement in mFARS scores in Friedreich ataxia pati…

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

Chemed To Report Third Quarter 2026 Earnings October 27, Related Conference Call To Be Held On October 28

Chemed Corporation announced it will release its third quarter 2026 financial results on October 27, 2026, after the NYSE market closes. The company will host a conference call on October 28 to discuss the results and provide business updates. Chemed operates VITAS Healthcare and Roto-Rooter, leaders in hospice care and plumbing services, respectiv…

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Carlsmed Appoints Tony Jarc as Chief Product and AI Officer

Carlsmed, Inc., a Nasdaq-listed medical technology company specializing in AI-enabled personalized spine surgery solutions, announced the appointment of Dr. Tony Jarc as Chief Product and AI Officer. Dr. Jarc brings significant AI and surgical technology expertise from Intuitive Surgical, aiming to advance Carlsmed's technology platform, user inter…

CBAK Energy Agrees on Battery Supply Framework with European Customer

CBAK Energy Agrees on Battery Supply Framework with European Customer

CBAK Energy Technology Limited announced a battery supply framework agreement with a major European technology company serving automotive and industrial markets. Initial cumulative orders exceed $4.5 million, with expected annual sales surpassing $30 million in 2027 and 2028. The partnership includes developing a new higher-capacity battery cell ex…

Airship AI Announces $29.0M of Firm Fixed Price Brand Name Only Awards from Department of Homeland Security

Airship AI Announces $29.0M of Firm Fixed Price Brand Name Only Awards from Department of Homeland Security

Airship AI Holdings, Inc. announced $29 million in firm-fixed-price contracts awarded by the Department of Homeland Security. The contracts support the development and deployment of AI-driven surveillance software and hardware, including enhancements to their Acropolis software ecosystem, Outpost AI edge devices, and the new Fortress AI server-side…

NBT Bancorp Inc. Announces Date of Third Quarter Conference Call

NBT Bancorp Inc. Announces Date of Third Quarter Conference Call

NBT Bancorp Inc. announced it will release its third quarter 2026 financial results on October 27, 2026, followed by a conference call on October 28 to review the results. The company operates as a financial holding company with a full-service community bank and financial services subsidiaries across multiple northeastern US states.

HP Brings Premium PC Experiences to More Consumers

HP Brings Premium PC Experiences to More Consumers

HP Inc. launched the HP OmniBook 5, a premium consumer laptop with vibrant OLED screens, AI-enhanced capabilities, long battery life, and portability, targeting students, professionals, and multitaskers. Alongside, HP introduced the ProBook 4, a thin, durable business notebook designed for SMBs with AI acceleration and premium features, enhancing p…

Kodiak AI Chooses AWS for AI-Powered Autonomous Trucking Technology Development Ahead of Driverless Highway Launch

Kodiak AI Chooses AWS for AI-Powered Autonomous Trucking Technology Development Ahead of Driverless Highway Launch

Kodiak AI, a Nasdaq-listed company developing autonomous trucking technology, has chosen Amazon Web Services (AWS) as its primary cloud provider. This partnership supports Kodiak's compute-intensive AI model training and safety simulations, critical for launching its driverless trucking service on public highways in Texas later in 2026. Utilizing A…